The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside

Clinical Infectious Diseases

Volumn 22, Issue SUPPL. 2, 1996, Pages

  Cole, Garry T ^a   Halawa, Abdul A ^b   Anaissie, Elias J ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CANDIDIASIS; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DISEASE SIMULATION; DISEASE TRANSMISSION; DRUG SCREENING; GASTROINTESTINAL TRANSIT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE MUCOSA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0030037019     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.supplement_2.s73     Document Type: Conference Paper

References (114)

1. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea & Febiger, 1992.
2. Gupta TP, Ehrinpreis MN. Candida-associated diarrhea in hospitalized patients. Gastroenterol 1988;94(5)(part 2)(suppl):A162.
3. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994;23:406-12.
4. Chandler FW, Kaplan W. Color atlas and text of the histopathology of mycotic diseases. Chicago: Yearbook Medical Publishers, 1980.
5. Jensen J, Warner T, Balish E. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis 1993;167:912-9.
6. Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980;25:1-10.
7. Wingard JR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 1994;19(suppl 1):S49-53.
8. Odds FC, Schmid J, Soll DR. Epidemiology of Candida infections in AIDS. In: Vanden Bossche H, MacKenzie DWR, Cauwenbergh G, Van Cutsem J, Drouhet E, Dupont B, eds. Mycoses in AIDS patients. New York: Plenum Press, 1990:67-74.
9. Wilcox CM, Karowe MW. Esophageal infections: etiology, diagnosis, and management. Gastroenterologist 1994;2:188-06.
10. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda: evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995;122:262-70.
11. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis 1994;19:684-6.
12. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994;32:2092-8.
13. Chavanet P, Lopez J, Grappin M, et al. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994;8:945-50.
14. Powderly WG. Resistant candidiasis. AIDS Res Hum Retroviruses 1994;10:925-9.
15. Wu-Hsieh B, Howard DH, Ahmed R. Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection. J Infect Dis 1988;158:232-5.
16. Moors MA, Jones SM, Klyczek KK, Rogers TJ, Buckley HR, Blank KJ. Effect of Friend leukemia virus infection on susceptibility to Candida albicans. Infect Immun 1990;58:1796-801.
17. Cole GT, Saha K, Seshan KR, Lynn KT, France M, Wong PKY. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun 1992;60:4168-78.
18. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-30.
19. Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990;58:1093-100.
20. + lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991;59:2447-55.
21. Pope LM, Cole GT, Guentzel MN, Berry LJ. Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge. Infect Immun 1979;25:702-17.
22. Samonis G, Anaissie EJ, Rosenbaum B, Bodey GP. A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice. Infect Immun 1990;58:1514-7.
23. Samonis G, Anaissie EJ, Bodey GP. Effects of broad-spectrum antimicrobiol agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 1990;34:2420-2.
24. Samonis G, Gikas A, Anaissie EJ, et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993;37:51-53.
25. Cole GT, Lynn KT, Seshan KR. Evaluation of a murine model of hepatic candidiasis. J Clin Microbiol 1990;28:1828-41.
26. Anaissie EJ, Karyotakis NC, Hachem R, Dignani MC, Rex JH, Paetznick V. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis 1994;170:384-9.
27. Walsh TJ, Van Cutsem J, Polak AM, Graybill JR. Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts. J Med Vet Mycol 1992;30(suppl 1):S225-40.
28. Walsh TJ, Lee JW. Prevention of invasive fungal infections in patients with neoplastic diseases. Clin Infect Dis 1993;17(suppl 2):S468-80.
29. Björkholm M. Chemoprophylaxis of fungal infections in neutropenic patients. Ann Oncol 1994;5:571-4.
30. Bodey GP, Anaissie EJ, Elting LS, Estey E, O'Brien S, Kantarjian H. Antifungal prophylaxis during remission induction therapy for acute leukemia: fluconazole versus intravenous amphotericin B. Cancer 1994;73:2099-06.
31. Vanden Bossche H, Odds FC, Stevens DA, Moskovitz BL, eds. Host-fungus interplay. Proceedings of the 5th Symposium on Topics in Mycology. New York: Plenum Press, 1996 (in press).
32. Cole GT, Seshan KR, Lynn KT, Franco M. Gastrointestinal candidiasis: histopathology of Candida-host interactions in a murine model. Mycol Res 1993;97:385-408.
33. Cole GT, Lynn KT, Seshan KR, Pope LM. Gastrointestinal and systemic candidosis in immunocompromised mice. J Med Vet Mycol 1989;27:363-80.
34. Ekenna O, Sherertz RJ. Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infect Immun 1987;55:1558-63.
35. Kennedy MJ. Adhesion and association mechanisms of Candida albicans. Curr Top Med Mycol 1988;2:73-169.
36. Kennedy MJ. Candida blastospore adhesion, association, and invasion of the gastrointestinal tract of vertebrates. In: Cole GT, Hoch HC, eds. The fungal spore and disease initiation in plants and animals. New York: Plenum Press, 1991:157-80.
37. Odds FC. Candida and candidosis. 2nd ed. London: Bailliére Tindall, 1988.
38. Rüchel R, De Bernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinases. J Med Vet Mycol 1992;30(suppl 1):S123-32.
39. Ray TL, Payne CD, Morrow BJ. Candida albicans acid proteinase: characterization and role in candidiasis. In: Dunn BM, ed. Structure and function of the aspartic proteinase: genetics, structures, and mechanisms. New York: Plenum Press, 1991:173-83.
40. Hattori M, Yoshiura K, Negi M, Ogawa H. Keratinolytic proteinase produced by Candida albicans. Sabouraudia 1984;22:175-83.
41. Ray TL, Payne CD. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun 1988;56:1942-9.
42. Ray TL, Payne CD. Role of Candida acid proteinase in adhesion and invasion of the murine epidermis [abstract no S5.5:D7]. In: Proceedings of the International Society for Human and Animal Mycoses Congress (Adelaide, Australia). Adelaide: University of Adelaide Press, 1994.
43. Monod M, Togni G, Hube B, Sanglard D. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 1994;13:357-68.
44. Hube B, Monod M, Schofield DA, Brown AJP, Gow NAR. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 1994;14:87-99.
45. Calderone RA, Braun PC. Adherence and receptor relationships of Candida albicans. Microbiol Rev 1991;55:1-20.
46. Hostetter MK. Interactions of Candida albicans with eukaryotic cells. ASM News 1994;60:370-4.
47. Hostetter MK. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev 1994;7:29-42.
48. Salyers AA, Whitt DD. Bacterial pathogenesis: a molecular approach. Washington, DC: American Society for Microbiology Press, 1994:169-80.
49. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
50. Bailey A, Wadsworth E, Calderone R. Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signaling events. Infect Immun 1995;63:569-72.
51. Kanbe T, Li R-K, Wadsworth E, Calderone RA, Cutler JE. Evidence for expression of the C3d receptor of Candida albicans in vitro and in vivo obtained by immunofluorescence and immunoelectron microscopy. Infect Immun 1991;59:1832-8.
52. Saxena A, Calderone R. Purification and characterization of the extracellular C3d-binding protein of Candida albicans. Infect Immun 1990;58:309-14.
53. Whelan WL, Delga JM, Wadsworth E, et al. Isolation and characterization of cell surface mutants of Candida albicans. Infect Immun. 1990;58:1552-7.
54. Murphy PM. Molecular mimicry and the generation of host defense protein diversity [letter]. Cell 1993;72:823-6.
55. Guentzel MN, Cole GT, Pope LM. Animal models for candidiasis. Curr Top Med Mycol 1985;1:57-116.
56. Diamond RD. Interactions of phagocytic cells with Candida and other opportunistic fungi. Arch Med Res 1993;24:361-9.
57. Calderone R, Sturtevant J. Macrophage interactions with Candida. Immunol Ser 1994;60:505-15.
58. Greenfield RA. Host defense system interactions with Candida. J Med Vet Mycol 1992;30:89-104.
59. Lyman CA, Walsh TJ. Phagocytosis of medically important yeasts by polymorphonuclear leukocytes. Infect Immun 1994;62:1489-93.
60. Domer JE. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit Rev Microbiol 1989;17:33-51.
61. Torosantucci A, Palma C, Boccanera M, Ausiello CM, Spagnoli GC, Cassone A. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J Gen Microbiol 1990;136:2155-63.
62. Djeu JY, Blanchard DK, Richards AL, Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988;141:4047-52.
63. Djeu JY, Serbousek D, Blanchard DK. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 1990;76:2205-9.
64. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1990; 144:2205-10.
65. Smith PD, Lamerson CL, Banks SM, et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990;161:999-1005.
66. Blanchard DK, Michelini-Norris MB, Djeu JY. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood 1991;77:2259-65.
67. Scaringi L, Blasi E, Rusati E, Marconi P, Bistoni F. Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro. J Gen Microbiol 1991;137: 2851-6.
68. Tennenberg SD. The effect of inflammatory mediators on neutrophil function. In: Hörl WH, Schollmeyer PJ, eds. New aspects of human polymorphonuclear leukocytes. New York: Plenum Press, 1991:75-92.
69. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-γ. J Infect Dis 1992;166:668-73.
70. Meunier F, Gérard M, Richard V, Debusscher L, Bleibert H, Malengrau A. Hepatic candidosis in a patient with acute leukemia. Mycoses 1989;32:421-6.
71. Verdeguer A, Fernandex JM, Esquembre C, Ferris J, Ruiz JG, Castel V. Hepatosplenic candidiasis in children with acute leukemia. Cancer 1990;65:874-7.
72. Marcus SG, Walsh TJ, Pizzo PA, Danforth DN Jr. Hepatic abscess in cancer patients. Characterization and management. Arch Surg 1993;128:1358-64.
73. Bodey GP, Anaissie E. Chronic systemic candidiasis. Eur J Clin Microbiol Infect Dis 1989;8:855-7.
74. Bach JF, Strom TB, eds. The mode of action of immunosuppressive agents. Vol. 9. Research monographs in immunology. New York: Elsevier, 1985.
75. Roy MJ, Walsh TJ. Histopathologic and immunohistochemical changes in gut-associated lymphoid tissues after treatment of rabbits with dexamethasone. Lab Invest 1992;66:437-43.
76. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Safety 1994;11:163-78.
77. Bistoni F, Vecchiarelli A, Cenci E, Sbaraglia G, Perito S, Cassone A. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. Sabouraudia 1984;22:409-18.
78. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974;179:697-711.
79. Guentzel MN, Herrera C. Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infect Immun 1982;35:222-8.
80. Cole GT, Lynn KT, Seshan KR. An animal model for oropharyngeal, esophageal and gastric candidosis. Mycoses 1990;33:7-19.
81. Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995;63:1993-8.
82. Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984;22:201-7.
83. Ghannoum MA, Filler SG, Ibrahim AS, Fu Y, Edwards JE Jr. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother 1992;36:2239-44.
84. Ibrahim AS, Filler SG, Ghannoum MA, Edwards JE Jr. Interferon-γ protects endothelial cells from damage by Candida albicans. J Infect Dis 1993;167:1467-70.
85. Pugh D, Cawson RA. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 1977;15:29-35.
86. Walsh TJ, Lee JW, Roilides E, et al. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases. Clin Infect Dis 1992;14(suppl 1):S139-47.
87. Walsh TJ, Aoki S, Mechinaud F, et al. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. J Infect Dis 1990;161:755-60.
88. Walsh TJ, Lee J, Aoki S, et al. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Rev Infect Dis 1990;12(suppl 3):S307-17.
89. Luna MA. Histological identification and pathologic patterns of disease caused by Candida. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis, and treatment. 2nd ed. New York: Raven Press, 1993:21.
90. Eras P, Goldstein MJ, Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972;51:367-79.
91. Walsh TJ, Merz WG. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol 1986;85:498-502.
92. Anaissie E, Pinczowski H, Louria DB. Candida infection in experimental animals. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis, and treatment. 2nd ed. New York: Raven Press, 1993:43.
93. Martino P, Girmenia C, Micozzi A, De Bernardis F, Boccanera M, Cassone A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 1994;13:797-804.
94. Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients: a retrospective study. Cancer 1989;64:2030-4.
95. Wade JC. Epidemiology of Candida infection. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis, and treatment. 2nd ed. New York: Raven Press, 1993:85.
96. Burnie JP, Matthews R, Lee W, et al. Four outbreaks of nosocomial systemic candidiasis. Epidemiol Infect 1987;99:201-11.
97. Tollemar J, Holmberg K, Ringden O, Lönnqvist B. Surveillance tests for the diagnosis of invasive fungal infection in bone marrow transplant recipients. Scand J Infect Dis 1989;21:205-12.
98. Pappu-Katikaneni LD, Roa KPP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990;33:20-3.
99. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):S43-53.
100. Giuliano M, Barza M, Jacobus NV, Gorbach SL. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 1987;31:202-6.
101. Spebar MJ, Pruitt BA Jr. Candidiasis in the burned patient. J Trauma 1981;21:237-9.
102. Walsh H, Hildebrandt RJ, Prystowsky H. Oral progestational agents as a cause of Candida vaginitis. Am J Obstet Gynecol 1968;101:991-3.
103. Triger DR, Goepel JR, Slater DN, Underwood JCE. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine. Lancet 1981;2:837-8.
104. Driks MR, Craven DE, Celii BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. N Engl J Med 1987;317:1376-82.
105. Brooks JR, Smith HF, Pease FB Jr. Bacteriology of the stomach immediately following vagotomy: the growth of Candida albicans. Ann Surg 1974;179:859-62.
106. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia; a case-control study in adults without leukemia. Am J Med 1989;87:614-20.
107. Silverman S Jr, Luangjarmekorn L, Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med 1984;39:194-6.
108. Goodrich JM, Reed EC, Mori M, et al. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 1991;164:731-40.
109. Krause W, Matheis H, Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969;1:598-9.
110. Alexander JW, Boyce ST, Babcock GF, et al. The process of microbial translocation. Ann Surg 1990;212:496-512.
111. Wolochow H, Hildebrand GJ, Lamanna C. Translocation of microorganisms across the intestinal wall of the rat: effect of microbial size and concentration. J Infect Dis 1966;116:523-8.
112. Wells CL, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 1988;10:958-79.
113. Vartivarian S, Smith CB. Pathogenesis, host resistance, and predisposing factors. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis, and treatment. 2nd ed. New York: Raven Press, 1993:59.
114. Bodey GP. Fungal infections complicating acute leukemia. J Chron Dis 1966;19:667-87.